STUDIES OF BENZ(A)ANTHRAQUINONE ANTIBIOTICS

苯并(A)蒽醌类抗生素的研究

基本信息

  • 批准号:
    2176284
  • 负责人:
  • 金额:
    $ 22.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1982
  • 资助国家:
    美国
  • 起止时间:
    1982-12-01 至 1999-03-31
  • 项目状态:
    已结题

项目摘要

The specific aims of this program focus on benz[a]anthraquinone- derived antibiotics. Work will be continued on the kinamycin antibiotics produced by Streptomyces murayamaensis, and on antibiotic PD 116740, produced by S. WP 4669. A limited set of experiments will be carried out in S. rimosus, in order to identify one of the key branch-points in the general matrix of benz[a]anthraquinone biosynthesis by examining the precursor/product relationship of tetrangomycin and tetrangulol. The Research Design includes structural studies to identify more biosynthetic intermediates in each pathway. This will be done by a combination of characterizing additional metabolites, and of synthesizing and testing reasonable candidates. In the kinamycin pathway, metabolites that are potentially intermediates will be identified by feeding known intermediates to a current set of 37 blocked mutants. The Research Design will include biochemical studies to detect and characterize key enzymes in these pathways (e.g. for amino- and amidotransferases, aryl epoxidases and arylepoxide hydrolases, hydroquinone epoxidases, and aromatic ringcleaving enzymes), and molecular genetics studies to clone, sequence, and characterize selected genes. The broad objective of this research program is to understand which chemical reactions are available in Nature and how they are linked together to produce complex structures with significant bio- medically relevant activity, in particular, antibiosis. This objective will be attained through the described multi-faceted approach that blends carefully chosen experiments in synthesis, biosynthesis, enzymology and molecular genetics. Such an interdisciplinary approach has become more and more essential for the modern bioorganic chemist who desires to study metabolism, its regulation and its consequences. It will lay the groundwork for applications such as modifying bioactivity by metabolic and genetic engineering to generate new molecular structures. This interdisciplinary approach is also an effective vehicle to train new chemists with an understanding of biology and a broad range of skills for solving important biochemical problems.
该计划的具体目标是奔驰[a]蒽醌-

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEVEN J GOULD其他文献

STEVEN J GOULD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEVEN J GOULD', 18)}}的其他基金

MEDIUM FIELD 5/9 TESLA FT NMR SPECTROMETER
中场 5/9 特斯拉 FT 核磁共振波谱仪
  • 批准号:
    3519943
  • 财政年份:
    1988
  • 资助金额:
    $ 22.4万
  • 项目类别:
STUDIES OF BENZ(A)ANTHRAQUINONE ANTIBIOTICS
苯并(A)蒽醌类抗生素的研究
  • 批准号:
    2176285
  • 财政年份:
    1982
  • 资助金额:
    $ 22.4万
  • 项目类别:
PEPTIDE AND PEPTIDE/NUCLEOSIDE ANTIBIOTICS
肽和肽/核苷抗生素
  • 批准号:
    2176440
  • 财政年份:
    1982
  • 资助金额:
    $ 22.4万
  • 项目类别:
BIOSYNTHETIC STUDIES USING 15N-13C CNMR SPECTROSCOPY
使用 15N-13C CNMR 光谱进行生物合成研究
  • 批准号:
    3280698
  • 财政年份:
    1982
  • 资助金额:
    $ 22.4万
  • 项目类别:
MUTASYNTHETIC & BIO-ORGANIC STUDIES OF ANTIBIOTICS
变异合成
  • 批准号:
    3279994
  • 财政年份:
    1982
  • 资助金额:
    $ 22.4万
  • 项目类别:
MUTASYNTHETIC AND BIOORGANIC STUDIES OF ANTIBIOTICS
抗生素的突变合成和生物有机研究
  • 批准号:
    3279988
  • 财政年份:
    1982
  • 资助金额:
    $ 22.4万
  • 项目类别:
MUTASYNTHETIC & BIO-ORGANIC STUDIES OF ANTIBIOTICS
变异合成
  • 批准号:
    3279989
  • 财政年份:
    1982
  • 资助金额:
    $ 22.4万
  • 项目类别:
STUDIES OF ENZYME REACTION MECHANISMS
酶反应机理的研究
  • 批准号:
    3280688
  • 财政年份:
    1982
  • 资助金额:
    $ 22.4万
  • 项目类别:
MUTASYNTHETIC AND BIOORGANIC STUDIES OF ANTIBIOTICS
抗生素的突变合成和生物有机研究
  • 批准号:
    3279992
  • 财政年份:
    1982
  • 资助金额:
    $ 22.4万
  • 项目类别:
MUTASYNTHETIC AND BIOORGANIC STUDIES OF ANTIBIOTICS
抗生素的突变合成和生物有机研究
  • 批准号:
    3279993
  • 财政年份:
    1982
  • 资助金额:
    $ 22.4万
  • 项目类别:

相似海外基金

Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
  • 批准号:
    2902098
  • 财政年份:
    2024
  • 资助金额:
    $ 22.4万
  • 项目类别:
    Studentship
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
  • 批准号:
    BB/Y004035/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.4万
  • 项目类别:
    Research Grant
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
  • 批准号:
    EP/Z533026/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.4万
  • 项目类别:
    Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
  • 批准号:
    FT230100468
  • 财政年份:
    2024
  • 资助金额:
    $ 22.4万
  • 项目类别:
    ARC Future Fellowships
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.4万
  • 项目类别:
    Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.4万
  • 项目类别:
    Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
  • 批准号:
    MR/Y033809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.4万
  • 项目类别:
    Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
  • 批准号:
    494853
  • 财政年份:
    2023
  • 资助金额:
    $ 22.4万
  • 项目类别:
    Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
  • 批准号:
    2884862
  • 财政年份:
    2023
  • 资助金额:
    $ 22.4万
  • 项目类别:
    Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
  • 批准号:
    2904356
  • 财政年份:
    2023
  • 资助金额:
    $ 22.4万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了